From single-to multi-target drugs in cancer therapy: when aspecificity becomes an advantage
Current medicinal chemistry, 2008 - ingentaconnect.com
Targeted therapies by means of compounds that inhibit a specific target molecule represent
a new perspective in the treatment of cancer. In contrast to conventional chemotherapy …
a new perspective in the treatment of cancer. In contrast to conventional chemotherapy …
[引用][C] From Single-to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage
S Giordano, A Petrelli - Current Medicinal Chemistry, 2008 - cir.nii.ac.jp
From Single- to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an
Advantage | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Advantage | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
From single-to multi-target drugs in cancer therapy: when aspecificity becomes an advantage
A Petrelli, S Giordano - CURRENT MEDICINAL CHEMISTRY, 2008 - iris.unito.it
Targeted therapies by means of compounds that inhibit a specific target molecule represent
a new perspective in the treatment of cancer. In contrast to conventional chemotherapy …
a new perspective in the treatment of cancer. In contrast to conventional chemotherapy …
[PDF][PDF] From Single-to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage
A Petrelli, S Giordano - Current Medicinal Chemistry, 2008 - researchgate.net
Targeted therapies by means of compounds that inhibit a specific target molecule represent
a new perspective in the treatment of cancer. In contrast to conventional chemotherapy …
a new perspective in the treatment of cancer. In contrast to conventional chemotherapy …
From single-to multi-target drugs in cancer therapy: when aspecificity becomes an advantage.
A Petrelli, S Giordano - Current Medicinal Chemistry, 2008 - europepmc.org
Targeted therapies by means of compounds that inhibit a specific target molecule represent
a new perspective in the treatment of cancer. In contrast to conventional chemotherapy …
a new perspective in the treatment of cancer. In contrast to conventional chemotherapy …
From single-to multi-target drugs in cancer therapy: when aspecificity becomes an advantage
A Petrelli, S Giordano - Current medicinal chemistry, 2008 - pubmed.ncbi.nlm.nih.gov
Targeted therapies by means of compounds that inhibit a specific target molecule represent
a new perspective in the treatment of cancer. In contrast to conventional chemotherapy …
a new perspective in the treatment of cancer. In contrast to conventional chemotherapy …
[引用][C] From Single-to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage
A PETRELLI, S GIORDANO - Current medicinal chemistry, 2008 - pascal-francis.inist.fr
From Single-to Multi-Target Drugs in Cancer Therapy : When Aspecificity Becomes an
Advantage CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
Advantage CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
From Single-to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage
S Giordano, A Petrelli - Current Medicinal Chemistry, 2008 - search.proquest.com
Targeted therapies by means of compounds that inhibit a specific target molecule represent
a new perspective in the treatment of cancer. In contrast to conventional chemotherapy …
a new perspective in the treatment of cancer. In contrast to conventional chemotherapy …